Upload
garren-low
View
643
Download
5
Tags:
Embed Size (px)
DESCRIPTION
Southern California American College of Surgeons 2014: "Subtotal Versus Total Cholecystectomy in Complicated Cholecystitis"
Citation preview
Subtotal Versus Total Cholecystectomy in Complicated
Cholecystitis
Daniel Kaplan, BA, Kenji Inaba, MD, Konstantinos Chouliaras, MD, Garren M. I. Low, MS, Elizabeth Benjamin, MD, Lydia Lam, MD,
Daniel Grabo, MD, Demetrios Demetriades, MD, PhD
LAC+USC Medical Center, Division of Trauma Surgery and Surgical Critical Care, University of Southern California, Los Angeles, CA
• No disclosures
Financial Disclosures
2
• 10-15% of adults developed world
• ~$6.2 billion annually
• Lap chole most common elective surgery US
Burden of Gallstone Disease
3Stinton L, Shaffer, E. Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer. Gut and Liver. 2012. Apr;6(2): 172-187.
4
Difficult Cholecystectomy• Severe inflammation • Fibrosis• Aberrant anatomy
Calot’s Triangle
Complications• CBD injury• Vascular injury• Hollow viscous injury
5
Conversion to Open total chole• Conversion rates vary btw 1.5-10%
Tang B, Cuschieri A. Conversions during laparoscopic cholecystectomy: risk factors and effects on patient outcome. J Gastrointest Surg. 2006. (10):1081-1091.
6
Subtotal Cholecystectomy• Introduced by
Bornman et al. 1985 to reduce CBD injury
• Involves excision of anterior wall and closure of cystic duct from within GB
Michalowski K, Bornman PC, Krige JE, Gallagher PJ, Terblanche J. Laparoscopic subtotal cholecystectomy in patients with complicated acute cholecystitis or fibrosis. Br J Surg. 1998 Jul;85(7):904-6.
7
Objective• To compare the outcomes between
subtotal cholecystectomy vs. open total cholecystectomy in patients with complicated cholecystitis
• Retrospective analysis• 1/2008 - 12/2012 (5 years)
• ICD-9 codes for Open Cholecystectomy and Subtotal Cholecystectomy
Methods
8
• Study groups• Subtotal Cholecystectomy (63)• Lap converted to OTC (151)
Methods
9
• Chart review• Preoperative labs • Imaging• Operative and discharge notes
Methods
10
• Outcomes• HLOS• ICU LOS• Intraoperative complications
• CBD injury• Vascular injury• Hollow viscous injury• Bile Leak• Retained Gallstones• Wound Infections• Subhepatic Abscesses
Methods
11
Severe Complications
SC (N=63) OTC (N=151)
p-value
Age 47.9±14.3 45.3±14.3 0.219
Gender (female)
54.0% 51.7% 0.758
Diabetes 12.7% 13.2% 0.914
HTN 17.5% 17.3% 0.966
Results: Demographics
12
Eleva
ted
Tot.
Bili (>
1.2)
Eleva
ted
Alk. P
hos (>
140)
Eleva
ted
ALT (>
56)
Eleva
ted
AST (>
40)
Eleva
ted
Lipa
se (>
100)
Eleva
ted
Amyl
ase
(>14
0)
Eleva
ted
Lact
ate
(>2.
2)0.00%
10.00%20.00%30.00%40.00%50.00%60.00%
SCOTC
Pre-op Labs
*WBC counts for SC and OTC groups were 13.7±4.7 and 14.3±5.4 respectively
Imaging and Operative Findings
0%
20%
40%
60%
SCOTC
SC (N=63) OTC (N=151)
p-value
HLOS 11.5±11 6.7±7 0.002
ICU LOS 3.9±7.3 4.9±10.8 0.685
Length of Stay
15
Complications
Wou
nd In
fect
ions
Vascu
lar I
njur
y
CBD inju
ry
Hol
low v
isco
us in
jury
Subh
epat
ic a
bsce
sses
Retai
ned
Ston
es
Fluid
col
lect
ions
Bile L
eaks
0.00%1.00%2.00%3.00%4.00%5.00%6.00%
Subtotal Open Total
*Only complications occurring after conversion were included in this analysis
SC (N=63) OTC (N=151)
p-value
Vascular Injury
0.0% 4.0% 0.325
CBD injury 0.0% 3.3% 0.108
Hollow Viscous
0.0% 0.6% 1.000
Total 0.0% 7.9% 0.036
Severe Complications
17
18
Conclusions• SC is a viable alternative• Significant decrease severe
complications• CBD injury + vascular injury + hollow
viscous• Further study is needed
• Prospective design using predictive scale to control for difficulty of cholecystectomy
Thank You